Singapore Hepatology
Conference 2024

26 July to 27 July 2024

8:30 am to 5:00 pm (SGT)

SHC 2024

26 July to 27 July 2024

8:30 am to 5.00 pm (SGT)

REGISTRATION FOR The Combined GIHep & Singapore Hepatology Conference includes SHC 2024!

We are committed to delivering Short, Focused Clinical Updates on all aspects of Hepatology from the World’s leading experts.

REGISTER HERE for the Combined Conference

To access SHC -e Resources REGISTER HERE or LOG IN (if you have previously registered for SHC)

MEET SOME OF OUR EXPERTS

SHC 2024 Preliminary Draft Scientific Programme

Download SHC 2024 Scientific Programme

July, 2024

26

Programme Time (SGT)
Welcome Remarks by the Conference Chairman and SHC partners 08:30 – 8:40
Chronic Hepatitis B symposium
Chairs:
Advances in HBV Cure 2024
– Prof. Man Fung Yuen, Hong Kong View Bio		 08:40 – 09:00
New guidelines for CHB
– Prof. Jidong Jia, China View Bio		 09:00 – 09:20
Debate: Should treatment be expanded
Yes: Prof. Man Fung Yuen, Hong Kong View Bio
No: Prof. Heiner Wedemeyer, Germany View Bio		 09:20 – 09:40
Stopping nucleoside analogue therapy: worth the risk?
– Prof. Harry Janssen, Netherlands View Bio		 09:40- 10:00
Update on management of HBV flares
– Prof. Teerha Piratvisuth, Thailand View Bio		 10:00 – 10:20
Round table discussion/Case discussion 10:20 – 10:40
Tea Break 10:40 – 11:00
Delta Cure Symposium
Chairs:
What is the prevalence of delta hepatitis and how do you diagnose it
– Prof. Pei Jer Chen, Taiwan View Bio		 11:00 – 11:20
What is delta cure and how to achieve it?
– Prof. Pietro Lampertico, Italy View Bio		 11:20 – 11:40
Treatment options for delta cirrhosis
– Prof. Heiner Wedemeyer, Germany View Bio		 11:40- 12:00
Round table/case discussion 12:00- 12:20
Lunch Symposium 12:20 – 14:00
NASH Symposium
Chairs:
NAFLD, MAFLD, MASLD – practical implications of a name change.
– Dr. George Goh, Singapore 		14:00 – 14:20
Community screening and care pathways in Fatty Liver Disease
– Prof. Wah Kheong Chan, Malaysia View Bio		 14:20 – 14:40
Selecting patients for pharmacological treatment
– Prof. Sven Francque, Belgium		 14:40 – 15:00
Debate: Vitamin E for NAFLD
Yes: Prof. Arun Sanyal View Bio
No: Prof. Vincent Wong View Bio		 15:00 – 15:20
Pearls and pitfalls on how to use GLP1 agonists
– Dr. Mark Muthiah, Singapore View Bio		 15:20 – 15:40
Summary of the inaugural Singapore NASH workshop
– Prof. Arun Sanyal View Bio		 15:40 – 16:00
Round table/case discussion 16:00 – 16:20
Tea Symposium 16:20 – 17:20
Fireside Chat with Hepatology experts: learning from the leaders
Chairs:
Featuring Rajender Reddy, Guadalupe Garcia-Tsao & Arun Sanyal 17:20 – 18:00
Dinner Symposium 18:00 – 20:00
End of day 1

July, 2024

27

Programme Time (SGT)
HCC Symposium
Chairs:
Hepatocellular surveillance: Barriers, gaps and new strategies
– Dr. Ken Liu, Australia  View Bio		 09:00 – 09:20
Role of non-invasive tests in NASH and HCC risk 09:20 – 09:40
Debate: Adjuvant therapy for HCC Cure
Yes: Prof. Pierce Chow, Singapore View Bio
No: Prof. Glenn Bonney, Singapore View Bio		 09:40 –10:00
Updates in systemic therapy for HCC: the way forward
– Dr. Cheng Ean Chee, Singapore View Bio		 10:00 – 10:20
Round-table /case discussion 10:20 – 10:40
Tea Break 10:40 – 11:00
Other Liver Diseases 
Chairs:
The forgotten disease: Alcoholic liver disease & MetALD
– Prof. Ajay Duseja, India View Bio		 11:00 – 11:20
Difficult to treat autoimmune hepatitis
– Prof. Atsushi Tanaka, Japan		 11:20 – 11:40
Biliary cirrhosis and sclerosing cholangitis: Update
– Prof. Atsushi Tanaka, Japan		 11:40- 12:00
Round table/Case discussion 12:00- 12:20
Lunch Symposium 12:40– 14:00
Advanced Liver Disease Management for the practising gastroenterologist/hepatologist
Chairs:
Optimising management of portal hypertension
– Prof. Guadalupe Garcia Tsao, USA View Bio		 14:00 – 14:20
Acute and acute on chronic liver failure
– Prof. Ajay Duseja, India View Bio		 14:20 – 14:40
Preventing complications of advanced liver disease
– Dr. Ken Liu, Australia  View Bio		 14:40 – 15:00
When to refer patients for liver transplantation
– Dr. Ruveena Bhavani Rajaram, Malaysia		 15:00 – 15:20
Futility in liver transplantation
– Prof. Rajender Reddy, USA View Bio		 15:20 – 15:40
Round table/cases discussion 15:40 – 16:00
Meet the Professor Tea Symposium 16:00– 17:00
Closing comments from the Chairman 17:00 – 17:10

Who Should Attend?

The SHC 2024 programme is designed for clinicians, scientists nurse practitioners, pharmacists, from Asia, the Indian Sub-continent, Australia and New Zealand, to exchange information on the latest research, discuss new developments in liver treatment and transplantation, and network with leading experts in the field  of hepatology.

Our Attendees Include:

  • Hepatology experts.
  • Clinical, basic, and translational researchers.
  • Specialists who diagnose and treat liver disease, including gastroenterologists, surgeons, clinical pathologists, anesthesiologists, and radiologists.
  • Primary care physicians.
  • Nurse practitioners, registered nurses, physician assistants, pharmacists, and other allied health professionals in hepatology and the disciplines listed above.
  • Trainees, and students in the disciplines listed above.

REGISTER HERE for the Combined Conference

To access SHC -e Resources REGISTER HERE or LOG IN (if you have previously registered for SHC)

Call for Abstracts

25 to 28 July 2024

8.30 am to 5.00 pm (SGT)

We invite all interested parties to present their research papers. Click Below on Abstracts and Posters for further information.

Abstracts will be reviewed by the Abstract Selection Committee and accepted submissions will be posted on Abstract & Poster Gallery in our website and in the Poster Hall.

The Abstract/Poster information and submission page will be open shortly.